Nitazoxanide, an antiviral thiazolide, depletes ATP-sensitive intracellular Ca(2+) stores

Omodele Ashiru1, Jonathon D Howe1, Terry D Butters1

  • 1Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, South Parks Road, Oxford, Oxfordshire OX1 3QU, UK.

Virology
|June 28, 2014
PubMed

Insights

Nitazoxanide (NTZ) depletes intracellular calcium stores, impacting viral replication. This mechanism underlies NTZ

Area of Science:

  • Virology
  • Cell Biology
  • Drug Discovery

Background:

  • Nitazoxanide (NTZ) is known to inhibit replication of several viruses.
  • Its effects on Flaviviridae family members, beyond Hepatitis C virus (HCV), are not well-defined.
  • Bovine viral diarrhoea virus (BVDV) serves as a surrogate model for HCV.

Purpose of the Study:

  • To investigate the effects of NTZ on BVDV replication.
  • To elucidate the molecular mechanisms underlying NTZ's antiviral activity.

Main Methods:

  • Treatment of cells with NTZ, with and without BVDV infection.
  • Measurement of PKR and eIF2α phosphorylation.
  • Assessment of intracellular calcium levels.
  • Analysis of ER stress markers and viral protein glycosylation/trafficking.

Main Results:

  • NTZ induced PKR and eIF2α phosphorylation in both uninfected and BVDV-infected cells.
  • NTZ treatment led to the depletion of ATP-sensitive intracellular calcium stores.
  • NTZ caused ER stress, altered viral protein N-linked glycosylation, and affected protein trafficking.
  • Cells adapted to ER stress by upregulating Ca(2+)-binding proteins like Bip and TCTP.

Conclusions:

  • Depletion of intracellular calcium stores is the primary consequence of NTZ treatment.
  • This calcium depletion is likely the key mechanism behind NTZ's antiviral effects against BVDV and potentially other viruses.

Related Concept Videos

Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
102
Antihypertensive Drugs: Thiazide-Class Diuretics01:15

Antihypertensive Drugs: Thiazide-Class Diuretics

Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
2.2K
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
57
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.7K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
1.0K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
2.7K